nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—Prednisone—prostate cancer	0.306	1	CrCtD
Ciclesonide—NR3C1—prostate cancer	0.104	0.633	CbGaD
Ciclesonide—CES1—Capecitabine—prostate cancer	0.0727	0.348	CbGbCtD
Ciclesonide—CYP3A4—prostate cancer	0.06	0.367	CbGaD
Ciclesonide—Testolactone—Estrone—prostate cancer	0.0437	0.212	CrCrCtD
Ciclesonide—NR3C1—Prednisone—prostate cancer	0.02	0.0958	CbGbCtD
Ciclesonide—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.018	0.086	CbGbCtD
Ciclesonide—CYP2D6—Bicalutamide—prostate cancer	0.0149	0.071	CbGbCtD
Ciclesonide—CYP2D6—Abiraterone—prostate cancer	0.0123	0.0588	CbGbCtD
Ciclesonide—Hydrocortamate—Prednisone—prostate cancer	0.0121	0.0586	CrCrCtD
Ciclesonide—Prednicarbate—Prednisone—prostate cancer	0.0114	0.0551	CrCrCtD
Ciclesonide—Testolactone—Prednisone—prostate cancer	0.0114	0.0551	CrCrCtD
Ciclesonide—Fluocortolone—Prednisone—prostate cancer	0.011	0.0536	CrCrCtD
Ciclesonide—Alclometasone—Prednisone—prostate cancer	0.0107	0.0521	CrCrCtD
Ciclesonide—Amcinonide—Prednisone—prostate cancer	0.0104	0.0507	CrCrCtD
Ciclesonide—Budesonide—Prednisone—prostate cancer	0.0104	0.0507	CrCrCtD
Ciclesonide—Desonide—Prednisone—prostate cancer	0.0102	0.0494	CrCrCtD
Ciclesonide—Clobetasol propionate—Prednisone—prostate cancer	0.0102	0.0494	CrCrCtD
Ciclesonide—Flunisolide—Prednisone—prostate cancer	0.0102	0.0494	CrCrCtD
Ciclesonide—Paramethasone—Prednisone—prostate cancer	0.00991	0.0481	CrCrCtD
Ciclesonide—CYP3A4—Bicalutamide—prostate cancer	0.00945	0.0452	CbGbCtD
Ciclesonide—Loteprednol—Prednisone—prostate cancer	0.00944	0.0458	CrCrCtD
Ciclesonide—Rimexolone—Prednisone—prostate cancer	0.00923	0.0448	CrCrCtD
Ciclesonide—Methylprednisolone—Prednisone—prostate cancer	0.00883	0.0428	CrCrCtD
Ciclesonide—CYP3A4—Estramustine—prostate cancer	0.00878	0.042	CbGbCtD
Ciclesonide—Prednisolone—Prednisone—prostate cancer	0.00864	0.0419	CrCrCtD
Ciclesonide—Hydrocortisone—Prednisone—prostate cancer	0.00829	0.0403	CrCrCtD
Ciclesonide—CYP3A4—Flutamide—prostate cancer	0.00783	0.0374	CbGbCtD
Ciclesonide—CYP3A4—Abiraterone—prostate cancer	0.00783	0.0374	CbGbCtD
Ciclesonide—CYP3A4—Cabazitaxel—prostate cancer	0.00579	0.0277	CbGbCtD
Ciclesonide—CYP3A4—Estrone—prostate cancer	0.00566	0.0271	CbGbCtD
Ciclesonide—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00504	0.0241	CbGbCtD
Ciclesonide—CYP3A4—Conjugated Estrogens—prostate cancer	0.0037	0.0177	CbGbCtD
Ciclesonide—CYP3A4—Mitoxantrone—prostate cancer	0.00337	0.0161	CbGbCtD
Ciclesonide—CYP3A4—Estradiol—prostate cancer	0.00325	0.0155	CbGbCtD
Ciclesonide—CYP3A4—Prednisone—prostate cancer	0.0028	0.0134	CbGbCtD
Ciclesonide—CYP2D6—Doxorubicin—prostate cancer	0.00228	0.0109	CbGbCtD
Ciclesonide—CYP3A4—Etoposide—prostate cancer	0.00212	0.0101	CbGbCtD
Ciclesonide—CYP3A4—Docetaxel—prostate cancer	0.00194	0.00928	CbGbCtD
Ciclesonide—CYP3A4—Doxorubicin—prostate cancer	0.00145	0.00692	CbGbCtD
Ciclesonide—NR3C1—urine—prostate cancer	0.00099	0.137	CbGeAlD
Ciclesonide—CES1—prostate gland—prostate cancer	0.000812	0.113	CbGeAlD
Ciclesonide—CYP3A4—urine—prostate cancer	0.000748	0.104	CbGeAlD
Ciclesonide—CYP2D6—urine—prostate cancer	0.000737	0.102	CbGeAlD
Ciclesonide—SERPINA6—renal system—prostate cancer	0.000553	0.0767	CbGeAlD
Ciclesonide—SERPINA6—bone marrow—prostate cancer	0.000418	0.058	CbGeAlD
Ciclesonide—CES1—testis—prostate cancer	0.000358	0.0496	CbGeAlD
Ciclesonide—NR3C1—prostate gland—prostate cancer	0.000355	0.0493	CbGeAlD
Ciclesonide—NR3C1—seminal vesicle—prostate cancer	0.000301	0.0417	CbGeAlD
Ciclesonide—Amcinonide—ANXA1—prostate cancer	0.000286	0.129	CrCbGaD
Ciclesonide—NR3C1—epithelium—prostate cancer	0.000261	0.0362	CbGeAlD
Ciclesonide—CES1—lymph node—prostate cancer	0.000259	0.036	CbGeAlD
Ciclesonide—NR3C1—renal system—prostate cancer	0.000242	0.0336	CbGeAlD
Ciclesonide—NR3C1—urethra—prostate cancer	0.000238	0.033	CbGeAlD
Ciclesonide—CYP3A4—renal system—prostate cancer	0.000183	0.0254	CbGeAlD
Ciclesonide—NR3C1—bone marrow—prostate cancer	0.000183	0.0254	CbGeAlD
Ciclesonide—CYP2D6—renal system—prostate cancer	0.00018	0.025	CbGeAlD
Ciclesonide—NR3C1—testis—prostate cancer	0.000157	0.0217	CbGeAlD
Ciclesonide—Hydrocortisone—ANXA1—prostate cancer	0.000121	0.0543	CrCbGaD
Ciclesonide—CYP2D6—testis—prostate cancer	0.000116	0.0162	CbGeAlD
Ciclesonide—Testolactone—CYP19A1—prostate cancer	0.000115	0.0518	CrCbGaD
Ciclesonide—NR3C1—lymph node—prostate cancer	0.000113	0.0157	CbGeAlD
Ciclesonide—Prednicarbate—NR3C1—prostate cancer	9.32e-05	0.042	CrCbGaD
Ciclesonide—Desonide—NR3C1—prostate cancer	8.82e-05	0.0397	CrCbGaD
Ciclesonide—Loteprednol—NR3C1—prostate cancer	8.5e-05	0.0383	CrCbGaD
Ciclesonide—Beclomethasone—CYP3A5—prostate cancer	8.04e-05	0.0362	CrCbGaD
Ciclesonide—Flurandrenolide—NR3C1—prostate cancer	7.53e-05	0.0339	CrCbGaD
Ciclesonide—Hydrocortamate—NR3C1—prostate cancer	7.29e-05	0.0328	CrCbGaD
Ciclesonide—Budesonide—NR3C1—prostate cancer	6.77e-05	0.0305	CrCbGaD
Ciclesonide—Amcinonide—NR3C1—prostate cancer	6.77e-05	0.0305	CrCbGaD
Ciclesonide—Rimexolone—NR3C1—prostate cancer	6.37e-05	0.0287	CrCbGaD
Ciclesonide—Fatigue—Goserelin—prostate cancer	6.13e-05	0.000865	CcSEcCtD
Ciclesonide—Palpitations—Estradiol—prostate cancer	6.1e-05	0.000861	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	6.08e-05	0.000858	CcSEcCtD
Ciclesonide—Bronchospasm—Capecitabine—prostate cancer	6.08e-05	0.000858	CcSEcCtD
Ciclesonide—Fatigue—Conjugated Estrogens—prostate cancer	6.07e-05	0.000857	CcSEcCtD
Ciclesonide—Nausea—Bicalutamide—prostate cancer	6.07e-05	0.000856	CcSEcCtD
Ciclesonide—Candida infection—Doxorubicin—prostate cancer	6.06e-05	0.000855	CcSEcCtD
Ciclesonide—Cough—Estradiol—prostate cancer	6.03e-05	0.00085	CcSEcCtD
Ciclesonide—Fluocinonide—NR3C1—prostate cancer	6.01e-05	0.0271	CrCbGaD
Ciclesonide—Beclomethasone—NR3C1—prostate cancer	6.01e-05	0.0271	CrCbGaD
Ciclesonide—Hypertension—Estradiol—prostate cancer	5.96e-05	0.000841	CcSEcCtD
Ciclesonide—Bronchitis—Capecitabine—prostate cancer	5.94e-05	0.000839	CcSEcCtD
Ciclesonide—Chest pain—Estradiol—prostate cancer	5.88e-05	0.000829	CcSEcCtD
Ciclesonide—Arthralgia—Estradiol—prostate cancer	5.88e-05	0.000829	CcSEcCtD
Ciclesonide—Alclometasone—NR3C1—prostate cancer	5.84e-05	0.0263	CrCbGaD
Ciclesonide—Weight increased—Docetaxel—prostate cancer	5.81e-05	0.00082	CcSEcCtD
Ciclesonide—Dry mouth—Estradiol—prostate cancer	5.75e-05	0.000811	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Capecitabine—prostate cancer	5.74e-05	0.00081	CcSEcCtD
Ciclesonide—Diabetes mellitus—Epirubicin—prostate cancer	5.73e-05	0.000808	CcSEcCtD
Ciclesonide—Pneumonia—Docetaxel—prostate cancer	5.73e-05	0.000808	CcSEcCtD
Ciclesonide—Dizziness—Ethinyl Estradiol—prostate cancer	5.71e-05	0.000806	CcSEcCtD
Ciclesonide—Infestation NOS—Docetaxel—prostate cancer	5.69e-05	0.000803	CcSEcCtD
Ciclesonide—Infestation—Docetaxel—prostate cancer	5.69e-05	0.000803	CcSEcCtD
Ciclesonide—Flunisolide—NR3C1—prostate cancer	5.68e-05	0.0256	CrCbGaD
Ciclesonide—Clobetasol propionate—NR3C1—prostate cancer	5.68e-05	0.0256	CrCbGaD
Ciclesonide—Urticaria—Goserelin—prostate cancer	5.65e-05	0.000797	CcSEcCtD
Ciclesonide—Weight increased—Capecitabine—prostate cancer	5.63e-05	0.000794	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Prednisone—prostate cancer	5.62e-05	0.000793	CcSEcCtD
Ciclesonide—Cough—Mitoxantrone—prostate cancer	5.62e-05	0.000792	CcSEcCtD
Ciclesonide—Paramethasone—NR3C1—prostate cancer	5.61e-05	0.0253	CrCbGaD
Ciclesonide—Infection—Estradiol—prostate cancer	5.6e-05	0.00079	CcSEcCtD
Ciclesonide—Urticaria—Conjugated Estrogens—prostate cancer	5.6e-05	0.000789	CcSEcCtD
Ciclesonide—Hypertension—Mitoxantrone—prostate cancer	5.56e-05	0.000784	CcSEcCtD
Ciclesonide—Immune system disorder—Etoposide—prostate cancer	5.55e-05	0.000783	CcSEcCtD
Ciclesonide—Pneumonia—Capecitabine—prostate cancer	5.54e-05	0.000782	CcSEcCtD
Ciclesonide—Mediastinal disorder—Etoposide—prostate cancer	5.54e-05	0.000782	CcSEcCtD
Ciclesonide—Conjunctivitis—Docetaxel—prostate cancer	5.53e-05	0.000781	CcSEcCtD
Ciclesonide—Infestation—Capecitabine—prostate cancer	5.51e-05	0.000777	CcSEcCtD
Ciclesonide—Infestation NOS—Capecitabine—prostate cancer	5.51e-05	0.000777	CcSEcCtD
Ciclesonide—Chest pain—Mitoxantrone—prostate cancer	5.48e-05	0.000773	CcSEcCtD
Ciclesonide—Arthralgia—Mitoxantrone—prostate cancer	5.48e-05	0.000773	CcSEcCtD
Ciclesonide—Rash—Ethinyl Estradiol—prostate cancer	5.45e-05	0.000768	CcSEcCtD
Ciclesonide—Dermatitis—Ethinyl Estradiol—prostate cancer	5.44e-05	0.000768	CcSEcCtD
Ciclesonide—Headache—Ethinyl Estradiol—prostate cancer	5.41e-05	0.000763	CcSEcCtD
Ciclesonide—Epistaxis—Docetaxel—prostate cancer	5.37e-05	0.000757	CcSEcCtD
Ciclesonide—Urinary tract infection—Capecitabine—prostate cancer	5.36e-05	0.000756	CcSEcCtD
Ciclesonide—Conjunctivitis—Capecitabine—prostate cancer	5.36e-05	0.000756	CcSEcCtD
Ciclesonide—Diabetes mellitus—Doxorubicin—prostate cancer	5.3e-05	0.000748	CcSEcCtD
Ciclesonide—Methylprednisolone—NR3C1—prostate cancer	5.3e-05	0.0238	CrCbGaD
Ciclesonide—Dysgeusia—Etoposide—prostate cancer	5.24e-05	0.000739	CcSEcCtD
Ciclesonide—Infection—Mitoxantrone—prostate cancer	5.22e-05	0.000736	CcSEcCtD
Ciclesonide—Epistaxis—Capecitabine—prostate cancer	5.2e-05	0.000733	CcSEcCtD
Ciclesonide—Back pain—Etoposide—prostate cancer	5.18e-05	0.00073	CcSEcCtD
Ciclesonide—Clobetasol propionate—CYP1A1—prostate cancer	5.16e-05	0.0232	CrCbGaD
Ciclesonide—Haemoglobin—Docetaxel—prostate cancer	5.14e-05	0.000725	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Estradiol—prostate cancer	5.14e-05	0.000724	CcSEcCtD
Ciclesonide—Nausea—Ethinyl Estradiol—prostate cancer	5.13e-05	0.000724	CcSEcCtD
Ciclesonide—Rhinitis—Docetaxel—prostate cancer	5.12e-05	0.000723	CcSEcCtD
Ciclesonide—Haemorrhage—Docetaxel—prostate cancer	5.11e-05	0.000721	CcSEcCtD
Ciclesonide—Asthenia—Goserelin—prostate cancer	5.1e-05	0.00072	CcSEcCtD
Ciclesonide—Pharyngitis—Docetaxel—prostate cancer	5.07e-05	0.000715	CcSEcCtD
Ciclesonide—Asthenia—Conjugated Estrogens—prostate cancer	5.05e-05	0.000713	CcSEcCtD
Ciclesonide—Dyspnoea—Estradiol—prostate cancer	5.03e-05	0.000709	CcSEcCtD
Ciclesonide—Weight increased—Prednisone—prostate cancer	5.01e-05	0.000707	CcSEcCtD
Ciclesonide—Pain in extremity—Epirubicin—prostate cancer	4.98e-05	0.000703	CcSEcCtD
Ciclesonide—Haemoglobin—Capecitabine—prostate cancer	4.97e-05	0.000701	CcSEcCtD
Ciclesonide—Dyspepsia—Estradiol—prostate cancer	4.96e-05	0.0007	CcSEcCtD
Ciclesonide—Rhinitis—Capecitabine—prostate cancer	4.96e-05	0.0007	CcSEcCtD
Ciclesonide—Haemorrhage—Capecitabine—prostate cancer	4.95e-05	0.000698	CcSEcCtD
Ciclesonide—Pharyngitis—Capecitabine—prostate cancer	4.91e-05	0.000693	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Estradiol—prostate cancer	4.87e-05	0.000686	CcSEcCtD
Ciclesonide—Fatigue—Estradiol—prostate cancer	4.86e-05	0.000686	CcSEcCtD
Ciclesonide—Prednisolone—CYP2A6—prostate cancer	4.84e-05	0.0218	CrCbGaD
Ciclesonide—Face oedema—Epirubicin—prostate cancer	4.81e-05	0.000679	CcSEcCtD
Ciclesonide—Hydrocortisone—SHBG—prostate cancer	4.8e-05	0.0216	CrCbGaD
Ciclesonide—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	4.79e-05	0.000675	CcSEcCtD
Ciclesonide—Dizziness—Goserelin—prostate cancer	4.7e-05	0.000663	CcSEcCtD
Ciclesonide—Dyspnoea—Mitoxantrone—prostate cancer	4.68e-05	0.000661	CcSEcCtD
Ciclesonide—Cough—Etoposide—prostate cancer	4.67e-05	0.000659	CcSEcCtD
Ciclesonide—Dizziness—Conjugated Estrogens—prostate cancer	4.66e-05	0.000657	CcSEcCtD
Ciclesonide—Dyspepsia—Mitoxantrone—prostate cancer	4.62e-05	0.000652	CcSEcCtD
Ciclesonide—Hypertension—Etoposide—prostate cancer	4.62e-05	0.000652	CcSEcCtD
Ciclesonide—Immune system disorder—Docetaxel—prostate cancer	4.62e-05	0.000651	CcSEcCtD
Ciclesonide—Pain in extremity—Doxorubicin—prostate cancer	4.61e-05	0.00065	CcSEcCtD
Ciclesonide—Mediastinal disorder—Docetaxel—prostate cancer	4.61e-05	0.00065	CcSEcCtD
Ciclesonide—Chest pain—Etoposide—prostate cancer	4.56e-05	0.000643	CcSEcCtD
Ciclesonide—Fatigue—Mitoxantrone—prostate cancer	4.53e-05	0.000639	CcSEcCtD
Ciclesonide—Rash—Goserelin—prostate cancer	4.48e-05	0.000632	CcSEcCtD
Ciclesonide—Dermatitis—Goserelin—prostate cancer	4.48e-05	0.000632	CcSEcCtD
Ciclesonide—Urticaria—Estradiol—prostate cancer	4.48e-05	0.000632	CcSEcCtD
Ciclesonide—Immune system disorder—Capecitabine—prostate cancer	4.47e-05	0.00063	CcSEcCtD
Ciclesonide—Mediastinal disorder—Capecitabine—prostate cancer	4.46e-05	0.000629	CcSEcCtD
Ciclesonide—Nasopharyngitis—Epirubicin—prostate cancer	4.46e-05	0.000628	CcSEcCtD
Ciclesonide—Headache—Goserelin—prostate cancer	4.45e-05	0.000628	CcSEcCtD
Ciclesonide—Face oedema—Doxorubicin—prostate cancer	4.45e-05	0.000628	CcSEcCtD
Ciclesonide—Rash—Conjugated Estrogens—prostate cancer	4.44e-05	0.000626	CcSEcCtD
Ciclesonide—Dermatitis—Conjugated Estrogens—prostate cancer	4.44e-05	0.000626	CcSEcCtD
Ciclesonide—Haemoglobin—Prednisone—prostate cancer	4.43e-05	0.000625	CcSEcCtD
Ciclesonide—Headache—Conjugated Estrogens—prostate cancer	4.41e-05	0.000622	CcSEcCtD
Ciclesonide—Haemorrhage—Prednisone—prostate cancer	4.41e-05	0.000622	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Epirubicin—prostate cancer	4.39e-05	0.00062	CcSEcCtD
Ciclesonide—Dysgeusia—Docetaxel—prostate cancer	4.36e-05	0.000615	CcSEcCtD
Ciclesonide—Infection—Etoposide—prostate cancer	4.34e-05	0.000612	CcSEcCtD
Ciclesonide—Influenza—Epirubicin—prostate cancer	4.31e-05	0.000607	CcSEcCtD
Ciclesonide—Back pain—Docetaxel—prostate cancer	4.3e-05	0.000607	CcSEcCtD
Ciclesonide—Nausea—Goserelin—prostate cancer	4.22e-05	0.000596	CcSEcCtD
Ciclesonide—Hydrocortamate—CYP3A4—prostate cancer	4.22e-05	0.019	CrCbGaD
Ciclesonide—Dysgeusia—Capecitabine—prostate cancer	4.22e-05	0.000595	CcSEcCtD
Ciclesonide—Nausea—Conjugated Estrogens—prostate cancer	4.18e-05	0.00059	CcSEcCtD
Ciclesonide—Urticaria—Mitoxantrone—prostate cancer	4.17e-05	0.000589	CcSEcCtD
Ciclesonide—Back pain—Capecitabine—prostate cancer	4.17e-05	0.000588	CcSEcCtD
Ciclesonide—Bronchitis—Epirubicin—prostate cancer	4.14e-05	0.000584	CcSEcCtD
Ciclesonide—Nasopharyngitis—Doxorubicin—prostate cancer	4.12e-05	0.000582	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Doxorubicin—prostate cancer	4.07e-05	0.000574	CcSEcCtD
Ciclesonide—Prednisone—NR3C1—prostate cancer	4.05e-05	0.0182	CrCbGaD
Ciclesonide—Asthenia—Estradiol—prostate cancer	4.04e-05	0.00057	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Epirubicin—prostate cancer	4e-05	0.000565	CcSEcCtD
Ciclesonide—Influenza—Doxorubicin—prostate cancer	3.98e-05	0.000562	CcSEcCtD
Ciclesonide—Immune system disorder—Prednisone—prostate cancer	3.98e-05	0.000562	CcSEcCtD
Ciclesonide—Palpitations—Docetaxel—prostate cancer	3.93e-05	0.000555	CcSEcCtD
Ciclesonide—Budesonide—CYP3A4—prostate cancer	3.93e-05	0.0177	CrCbGaD
Ciclesonide—Weight increased—Epirubicin—prostate cancer	3.92e-05	0.000553	CcSEcCtD
Ciclesonide—Dyspnoea—Etoposide—prostate cancer	3.89e-05	0.000549	CcSEcCtD
Ciclesonide—Cough—Docetaxel—prostate cancer	3.88e-05	0.000548	CcSEcCtD
Ciclesonide—Pneumonia—Epirubicin—prostate cancer	3.86e-05	0.000545	CcSEcCtD
Ciclesonide—Hypertension—Docetaxel—prostate cancer	3.84e-05	0.000542	CcSEcCtD
Ciclesonide—Infestation NOS—Epirubicin—prostate cancer	3.84e-05	0.000542	CcSEcCtD
Ciclesonide—Infestation—Epirubicin—prostate cancer	3.84e-05	0.000542	CcSEcCtD
Ciclesonide—Bronchitis—Doxorubicin—prostate cancer	3.83e-05	0.000541	CcSEcCtD
Ciclesonide—Hydrocortisone—CYP3A5—prostate cancer	3.82e-05	0.0172	CrCbGaD
Ciclesonide—Palpitations—Capecitabine—prostate cancer	3.81e-05	0.000537	CcSEcCtD
Ciclesonide—Arthralgia—Docetaxel—prostate cancer	3.79e-05	0.000534	CcSEcCtD
Ciclesonide—Chest pain—Docetaxel—prostate cancer	3.79e-05	0.000534	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Etoposide—prostate cancer	3.77e-05	0.000532	CcSEcCtD
Ciclesonide—Asthenia—Mitoxantrone—prostate cancer	3.77e-05	0.000532	CcSEcCtD
Ciclesonide—Fatigue—Etoposide—prostate cancer	3.77e-05	0.000531	CcSEcCtD
Ciclesonide—Cough—Capecitabine—prostate cancer	3.76e-05	0.00053	CcSEcCtD
Ciclesonide—Prednisolone—NR3C1—prostate cancer	3.73e-05	0.0168	CrCbGaD
Ciclesonide—Conjunctivitis—Epirubicin—prostate cancer	3.73e-05	0.000526	CcSEcCtD
Ciclesonide—Urinary tract infection—Epirubicin—prostate cancer	3.73e-05	0.000526	CcSEcCtD
Ciclesonide—Dizziness—Estradiol—prostate cancer	3.73e-05	0.000526	CcSEcCtD
Ciclesonide—Hypertension—Capecitabine—prostate cancer	3.72e-05	0.000525	CcSEcCtD
Ciclesonide—Dry mouth—Docetaxel—prostate cancer	3.7e-05	0.000522	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Doxorubicin—prostate cancer	3.7e-05	0.000522	CcSEcCtD
Ciclesonide—Prednisone—CYP2C19—prostate cancer	3.69e-05	0.0166	CrCbGaD
Ciclesonide—Chest pain—Capecitabine—prostate cancer	3.67e-05	0.000517	CcSEcCtD
Ciclesonide—Arthralgia—Capecitabine—prostate cancer	3.67e-05	0.000517	CcSEcCtD
Ciclesonide—Weight increased—Doxorubicin—prostate cancer	3.63e-05	0.000512	CcSEcCtD
Ciclesonide—Epistaxis—Epirubicin—prostate cancer	3.62e-05	0.000511	CcSEcCtD
Ciclesonide—Infection—Docetaxel—prostate cancer	3.61e-05	0.000509	CcSEcCtD
Ciclesonide—Sinusitis—Epirubicin—prostate cancer	3.6e-05	0.000508	CcSEcCtD
Ciclesonide—Dry mouth—Capecitabine—prostate cancer	3.59e-05	0.000506	CcSEcCtD
Ciclesonide—Pneumonia—Doxorubicin—prostate cancer	3.57e-05	0.000504	CcSEcCtD
Ciclesonide—Rash—Estradiol—prostate cancer	3.55e-05	0.000501	CcSEcCtD
Ciclesonide—Infestation—Doxorubicin—prostate cancer	3.55e-05	0.000501	CcSEcCtD
Ciclesonide—Infestation NOS—Doxorubicin—prostate cancer	3.55e-05	0.000501	CcSEcCtD
Ciclesonide—Dermatitis—Estradiol—prostate cancer	3.55e-05	0.000501	CcSEcCtD
Ciclesonide—Headache—Estradiol—prostate cancer	3.53e-05	0.000498	CcSEcCtD
Ciclesonide—Angioedema—Prednisone—prostate cancer	3.51e-05	0.000494	CcSEcCtD
Ciclesonide—Infection—Capecitabine—prostate cancer	3.49e-05	0.000493	CcSEcCtD
Ciclesonide—Urticaria—Etoposide—prostate cancer	3.47e-05	0.00049	CcSEcCtD
Ciclesonide—Haemoglobin—Epirubicin—prostate cancer	3.46e-05	0.000489	CcSEcCtD
Ciclesonide—Rhinitis—Epirubicin—prostate cancer	3.46e-05	0.000487	CcSEcCtD
Ciclesonide—Urinary tract infection—Doxorubicin—prostate cancer	3.45e-05	0.000487	CcSEcCtD
Ciclesonide—Conjunctivitis—Doxorubicin—prostate cancer	3.45e-05	0.000487	CcSEcCtD
Ciclesonide—Haemorrhage—Epirubicin—prostate cancer	3.45e-05	0.000486	CcSEcCtD
Ciclesonide—Pharyngitis—Epirubicin—prostate cancer	3.42e-05	0.000483	CcSEcCtD
Ciclesonide—Alclometasone—CYP3A4—prostate cancer	3.38e-05	0.0152	CrCbGaD
Ciclesonide—Epistaxis—Doxorubicin—prostate cancer	3.35e-05	0.000473	CcSEcCtD
Ciclesonide—Nausea—Estradiol—prostate cancer	3.35e-05	0.000472	CcSEcCtD
Ciclesonide—Sinusitis—Doxorubicin—prostate cancer	3.33e-05	0.00047	CcSEcCtD
Ciclesonide—Hypertension—Prednisone—prostate cancer	3.31e-05	0.000467	CcSEcCtD
Ciclesonide—Rash—Mitoxantrone—prostate cancer	3.31e-05	0.000467	CcSEcCtD
Ciclesonide—Dermatitis—Mitoxantrone—prostate cancer	3.31e-05	0.000467	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.31e-05	0.000467	CcSEcCtD
Ciclesonide—Flunisolide—CYP3A4—prostate cancer	3.29e-05	0.0148	CrCbGaD
Ciclesonide—Headache—Mitoxantrone—prostate cancer	3.29e-05	0.000464	CcSEcCtD
Ciclesonide—Arthralgia—Prednisone—prostate cancer	3.27e-05	0.000461	CcSEcCtD
Ciclesonide—Paramethasone—CYP3A4—prostate cancer	3.25e-05	0.0147	CrCbGaD
Ciclesonide—Dyspnoea—Docetaxel—prostate cancer	3.24e-05	0.000457	CcSEcCtD
Ciclesonide—Haemoglobin—Doxorubicin—prostate cancer	3.21e-05	0.000452	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.2e-05	0.000452	CcSEcCtD
Ciclesonide—Rhinitis—Doxorubicin—prostate cancer	3.2e-05	0.000451	CcSEcCtD
Ciclesonide—Dyspepsia—Docetaxel—prostate cancer	3.2e-05	0.000451	CcSEcCtD
Ciclesonide—Haemorrhage—Doxorubicin—prostate cancer	3.19e-05	0.00045	CcSEcCtD
Ciclesonide—Pharyngitis—Doxorubicin—prostate cancer	3.17e-05	0.000447	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Docetaxel—prostate cancer	3.13e-05	0.000442	CcSEcCtD
Ciclesonide—Asthenia—Etoposide—prostate cancer	3.13e-05	0.000442	CcSEcCtD
Ciclesonide—Dyspnoea—Capecitabine—prostate cancer	3.13e-05	0.000442	CcSEcCtD
Ciclesonide—Fatigue—Docetaxel—prostate cancer	3.13e-05	0.000442	CcSEcCtD
Ciclesonide—Nausea—Mitoxantrone—prostate cancer	3.12e-05	0.00044	CcSEcCtD
Ciclesonide—Immune system disorder—Epirubicin—prostate cancer	3.11e-05	0.000439	CcSEcCtD
Ciclesonide—Infection—Prednisone—prostate cancer	3.11e-05	0.000439	CcSEcCtD
Ciclesonide—Mediastinal disorder—Epirubicin—prostate cancer	3.11e-05	0.000438	CcSEcCtD
Ciclesonide—Dyspepsia—Capecitabine—prostate cancer	3.09e-05	0.000436	CcSEcCtD
Ciclesonide—Methylprednisolone—CYP3A4—prostate cancer	3.07e-05	0.0138	CrCbGaD
Ciclesonide—Gastrointestinal disorder—Capecitabine—prostate cancer	3.03e-05	0.000428	CcSEcCtD
Ciclesonide—Fatigue—Capecitabine—prostate cancer	3.03e-05	0.000427	CcSEcCtD
Ciclesonide—Dysgeusia—Epirubicin—prostate cancer	2.94e-05	0.000414	CcSEcCtD
Ciclesonide—Back pain—Epirubicin—prostate cancer	2.9e-05	0.000409	CcSEcCtD
Ciclesonide—Dizziness—Etoposide—prostate cancer	2.89e-05	0.000408	CcSEcCtD
Ciclesonide—Immune system disorder—Doxorubicin—prostate cancer	2.88e-05	0.000406	CcSEcCtD
Ciclesonide—Mediastinal disorder—Doxorubicin—prostate cancer	2.87e-05	0.000405	CcSEcCtD
Ciclesonide—Hydrocortisone—NR3C1—prostate cancer	2.86e-05	0.0129	CrCbGaD
Ciclesonide—Musculoskeletal discomfort—Prednisone—prostate cancer	2.85e-05	0.000402	CcSEcCtD
Ciclesonide—Urticaria—Capecitabine—prostate cancer	2.79e-05	0.000394	CcSEcCtD
Ciclesonide—Dyspepsia—Prednisone—prostate cancer	2.76e-05	0.000389	CcSEcCtD
Ciclesonide—Rash—Etoposide—prostate cancer	2.75e-05	0.000389	CcSEcCtD
Ciclesonide—Dermatitis—Etoposide—prostate cancer	2.75e-05	0.000388	CcSEcCtD
Ciclesonide—Headache—Etoposide—prostate cancer	2.74e-05	0.000386	CcSEcCtD
Ciclesonide—Dysgeusia—Doxorubicin—prostate cancer	2.72e-05	0.000384	CcSEcCtD
Ciclesonide—Fatigue—Prednisone—prostate cancer	2.7e-05	0.000381	CcSEcCtD
Ciclesonide—Back pain—Doxorubicin—prostate cancer	2.69e-05	0.000379	CcSEcCtD
Ciclesonide—Palpitations—Epirubicin—prostate cancer	2.65e-05	0.000374	CcSEcCtD
Ciclesonide—Cough—Epirubicin—prostate cancer	2.62e-05	0.000369	CcSEcCtD
Ciclesonide—Asthenia—Docetaxel—prostate cancer	2.6e-05	0.000367	CcSEcCtD
Ciclesonide—Nausea—Etoposide—prostate cancer	2.59e-05	0.000366	CcSEcCtD
Ciclesonide—Hypertension—Epirubicin—prostate cancer	2.59e-05	0.000365	CcSEcCtD
Ciclesonide—Arthralgia—Epirubicin—prostate cancer	2.55e-05	0.00036	CcSEcCtD
Ciclesonide—Chest pain—Epirubicin—prostate cancer	2.55e-05	0.00036	CcSEcCtD
Ciclesonide—Asthenia—Capecitabine—prostate cancer	2.52e-05	0.000356	CcSEcCtD
Ciclesonide—Dry mouth—Epirubicin—prostate cancer	2.5e-05	0.000352	CcSEcCtD
Ciclesonide—Urticaria—Prednisone—prostate cancer	2.49e-05	0.000351	CcSEcCtD
Ciclesonide—Palpitations—Doxorubicin—prostate cancer	2.45e-05	0.000346	CcSEcCtD
Ciclesonide—Infection—Epirubicin—prostate cancer	2.43e-05	0.000343	CcSEcCtD
Ciclesonide—Cough—Doxorubicin—prostate cancer	2.42e-05	0.000342	CcSEcCtD
Ciclesonide—Dizziness—Docetaxel—prostate cancer	2.4e-05	0.000339	CcSEcCtD
Ciclesonide—Hypertension—Doxorubicin—prostate cancer	2.4e-05	0.000338	CcSEcCtD
Ciclesonide—Chest pain—Doxorubicin—prostate cancer	2.36e-05	0.000333	CcSEcCtD
Ciclesonide—Arthralgia—Doxorubicin—prostate cancer	2.36e-05	0.000333	CcSEcCtD
Ciclesonide—Prednisone—CYP3A4—prostate cancer	2.35e-05	0.0106	CrCbGaD
Ciclesonide—Dizziness—Capecitabine—prostate cancer	2.32e-05	0.000328	CcSEcCtD
Ciclesonide—Dry mouth—Doxorubicin—prostate cancer	2.31e-05	0.000326	CcSEcCtD
Ciclesonide—Rash—Docetaxel—prostate cancer	2.29e-05	0.000323	CcSEcCtD
Ciclesonide—Dermatitis—Docetaxel—prostate cancer	2.29e-05	0.000323	CcSEcCtD
Ciclesonide—Headache—Docetaxel—prostate cancer	2.27e-05	0.000321	CcSEcCtD
Ciclesonide—Infection—Doxorubicin—prostate cancer	2.25e-05	0.000318	CcSEcCtD
Ciclesonide—Asthenia—Prednisone—prostate cancer	2.25e-05	0.000317	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.23e-05	0.000315	CcSEcCtD
Ciclesonide—Rash—Capecitabine—prostate cancer	2.22e-05	0.000313	CcSEcCtD
Ciclesonide—Dermatitis—Capecitabine—prostate cancer	2.21e-05	0.000312	CcSEcCtD
Ciclesonide—Headache—Capecitabine—prostate cancer	2.2e-05	0.000311	CcSEcCtD
Ciclesonide—Dyspnoea—Epirubicin—prostate cancer	2.18e-05	0.000308	CcSEcCtD
Ciclesonide—Prednisolone—CYP3A4—prostate cancer	2.16e-05	0.00975	CrCbGaD
Ciclesonide—Nausea—Docetaxel—prostate cancer	2.16e-05	0.000304	CcSEcCtD
Ciclesonide—Dyspepsia—Epirubicin—prostate cancer	2.16e-05	0.000304	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Epirubicin—prostate cancer	2.11e-05	0.000298	CcSEcCtD
Ciclesonide—Fatigue—Epirubicin—prostate cancer	2.11e-05	0.000298	CcSEcCtD
Ciclesonide—Nausea—Capecitabine—prostate cancer	2.09e-05	0.000295	CcSEcCtD
Ciclesonide—Dizziness—Prednisone—prostate cancer	2.07e-05	0.000292	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.06e-05	0.000291	CcSEcCtD
Ciclesonide—Dyspnoea—Doxorubicin—prostate cancer	2.02e-05	0.000285	CcSEcCtD
Ciclesonide—Dyspepsia—Doxorubicin—prostate cancer	1.99e-05	0.000281	CcSEcCtD
Ciclesonide—Rash—Prednisone—prostate cancer	1.97e-05	0.000278	CcSEcCtD
Ciclesonide—Dermatitis—Prednisone—prostate cancer	1.97e-05	0.000278	CcSEcCtD
Ciclesonide—Headache—Prednisone—prostate cancer	1.96e-05	0.000277	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.96e-05	0.000276	CcSEcCtD
Ciclesonide—Fatigue—Doxorubicin—prostate cancer	1.95e-05	0.000276	CcSEcCtD
Ciclesonide—Urticaria—Epirubicin—prostate cancer	1.95e-05	0.000274	CcSEcCtD
Ciclesonide—Nausea—Prednisone—prostate cancer	1.86e-05	0.000262	CcSEcCtD
Ciclesonide—Urticaria—Doxorubicin—prostate cancer	1.8e-05	0.000254	CcSEcCtD
Ciclesonide—Asthenia—Epirubicin—prostate cancer	1.76e-05	0.000248	CcSEcCtD
Ciclesonide—Hydrocortisone—CYP3A4—prostate cancer	1.66e-05	0.00745	CrCbGaD
Ciclesonide—Asthenia—Doxorubicin—prostate cancer	1.63e-05	0.000229	CcSEcCtD
Ciclesonide—Dizziness—Epirubicin—prostate cancer	1.62e-05	0.000228	CcSEcCtD
Ciclesonide—Rash—Epirubicin—prostate cancer	1.54e-05	0.000218	CcSEcCtD
Ciclesonide—Dermatitis—Epirubicin—prostate cancer	1.54e-05	0.000218	CcSEcCtD
Ciclesonide—Headache—Epirubicin—prostate cancer	1.53e-05	0.000216	CcSEcCtD
Ciclesonide—Dizziness—Doxorubicin—prostate cancer	1.5e-05	0.000211	CcSEcCtD
Ciclesonide—Nausea—Epirubicin—prostate cancer	1.45e-05	0.000205	CcSEcCtD
Ciclesonide—Rash—Doxorubicin—prostate cancer	1.43e-05	0.000202	CcSEcCtD
Ciclesonide—Dermatitis—Doxorubicin—prostate cancer	1.43e-05	0.000201	CcSEcCtD
Ciclesonide—Headache—Doxorubicin—prostate cancer	1.42e-05	0.0002	CcSEcCtD
Ciclesonide—Nausea—Doxorubicin—prostate cancer	1.35e-05	0.00019	CcSEcCtD
Ciclesonide—NR3C1—Gene Expression—RPL10—prostate cancer	9.18e-06	0.000263	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	9.08e-06	0.00026	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HIST1H2BG—prostate cancer	9.01e-06	0.000258	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	8.96e-06	0.000256	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GGT1—prostate cancer	8.79e-06	0.000252	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HIST1H4H—prostate cancer	8.71e-06	0.000249	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NPPA—prostate cancer	8.71e-06	0.000249	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—PPARA—prostate cancer	8.69e-06	0.000249	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—NCOA1—prostate cancer	8.66e-06	0.000248	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MED12—prostate cancer	8.56e-06	0.000245	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	8.54e-06	0.000244	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PSAT1—prostate cancer	8.47e-06	0.000242	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CBR1—prostate cancer	8.47e-06	0.000242	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CSAD—prostate cancer	8.47e-06	0.000242	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ADI1—prostate cancer	8.47e-06	0.000242	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TST—prostate cancer	8.47e-06	0.000242	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GRHL1—prostate cancer	8.47e-06	0.000242	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IL6—prostate cancer	8.43e-06	0.000241	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	8.42e-06	0.000241	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—RXRA—prostate cancer	8.24e-06	0.000236	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—COMT—prostate cancer	7.94e-06	0.000227	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTP1—prostate cancer	7.9e-06	0.000226	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—UGT2B17—prostate cancer	7.87e-06	0.000225	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GRHPR—prostate cancer	7.87e-06	0.000225	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—UGT2B15—prostate cancer	7.87e-06	0.000225	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CKMT2—prostate cancer	7.87e-06	0.000225	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—ESR1—prostate cancer	7.87e-06	0.000225	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	7.83e-06	0.000224	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	7.79e-06	0.000223	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PGAM2—prostate cancer	7.4e-06	0.000212	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SULT2B1—prostate cancer	7.4e-06	0.000212	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NAGLU—prostate cancer	7.4e-06	0.000212	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTM3—prostate cancer	7.4e-06	0.000212	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—RFK—prostate cancer	7.4e-06	0.000212	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AOX1—prostate cancer	7.4e-06	0.000212	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MBTPS1—prostate cancer	7.4e-06	0.000212	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	7.28e-06	0.000209	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPS19—prostate cancer	7.28e-06	0.000208	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTM1—prostate cancer	7.26e-06	0.000208	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	7.16e-06	0.000205	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP3A43—prostate cancer	7.02e-06	0.000201	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AMACR—prostate cancer	7.02e-06	0.000201	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NAT1—prostate cancer	7.02e-06	0.000201	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SRD5A2—prostate cancer	7.02e-06	0.000201	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—DEGS1—prostate cancer	7.02e-06	0.000201	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—DNMT1—prostate cancer	6.96e-06	0.000199	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	6.9e-06	0.000197	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	6.88e-06	0.000197	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NCOA2—prostate cancer	6.83e-06	0.000196	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HAO1—prostate cancer	6.79e-06	0.000194	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	6.79e-06	0.000194	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—EZH2—prostate cancer	6.74e-06	0.000193	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HSD17B1—prostate cancer	6.69e-06	0.000192	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PARP1—prostate cancer	6.6e-06	0.000189	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	6.47e-06	0.000185	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HSPA1A—prostate cancer	6.25e-06	0.000179	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ESR2—prostate cancer	6.25e-06	0.000179	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HPGD—prostate cancer	5.97e-06	0.000171	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—B4GALT4—prostate cancer	5.97e-06	0.000171	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NCOA1—prostate cancer	5.76e-06	0.000165	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TNFRSF21—prostate cancer	5.61e-06	0.000161	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PSAT1—prostate cancer	5.54e-06	0.000159	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GRHL1—prostate cancer	5.54e-06	0.000159	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TST—prostate cancer	5.54e-06	0.000159	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CSAD—prostate cancer	5.54e-06	0.000159	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CBR1—prostate cancer	5.54e-06	0.000159	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ADI1—prostate cancer	5.54e-06	0.000159	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—AR—prostate cancer	5.52e-06	0.000158	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RXRA—prostate cancer	5.48e-06	0.000157	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP7B1—prostate cancer	5.46e-06	0.000156	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MTAP—prostate cancer	5.46e-06	0.000156	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SULT1E1—prostate cancer	5.32e-06	0.000152	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SRD5A1—prostate cancer	5.32e-06	0.000152	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—UGT2B15—prostate cancer	5.15e-06	0.000147	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—UGT2B17—prostate cancer	5.15e-06	0.000147	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CKMT2—prostate cancer	5.15e-06	0.000147	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GRHPR—prostate cancer	5.15e-06	0.000147	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ACSL4—prostate cancer	5.07e-06	0.000145	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HSD17B3—prostate cancer	5.07e-06	0.000145	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SIRT1—prostate cancer	5.03e-06	0.000144	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—VDR—prostate cancer	4.96e-06	0.000142	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—UMPS—prostate cancer	4.86e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PHGDH—prostate cancer	4.86e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ARG2—prostate cancer	4.86e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PGAM2—prostate cancer	4.84e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NAGLU—prostate cancer	4.84e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SULT2B1—prostate cancer	4.84e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTM3—prostate cancer	4.84e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AOX1—prostate cancer	4.84e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—RFK—prostate cancer	4.84e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MBTPS1—prostate cancer	4.84e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LDHB—prostate cancer	4.77e-06	0.000137	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP3A5—prostate cancer	4.68e-06	0.000134	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AMACR—prostate cancer	4.59e-06	0.000131	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP3A43—prostate cancer	4.59e-06	0.000131	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SRD5A2—prostate cancer	4.59e-06	0.000131	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—DEGS1—prostate cancer	4.59e-06	0.000131	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NAT1—prostate cancer	4.59e-06	0.000131	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ERCC2—prostate cancer	4.54e-06	0.00013	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PDHA1—prostate cancer	4.52e-06	0.000129	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TCN2—prostate cancer	4.52e-06	0.000129	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTA3—prostate cancer	4.52e-06	0.000129	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—UCP3—prostate cancer	4.52e-06	0.000129	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HSD17B1—prostate cancer	4.38e-06	0.000125	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC22A3—prostate cancer	4.31e-06	0.000124	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HSD3B1—prostate cancer	4.31e-06	0.000124	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PPARA—prostate cancer	4.18e-06	0.00012	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTA4—prostate cancer	4.14e-06	0.000118	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TBXAS1—prostate cancer	4.14e-06	0.000118	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	4.09e-06	0.000117	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTA2—prostate cancer	4.03e-06	0.000115	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCG5—prostate cancer	3.98e-06	0.000114	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SULT1A1—prostate cancer	3.98e-06	0.000114	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—B4GALT4—prostate cancer	3.9e-06	0.000112	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HPGD—prostate cancer	3.9e-06	0.000112	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTA1—prostate cancer	3.89e-06	0.000111	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NAT2—prostate cancer	3.84e-06	0.00011	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HSD3B2—prostate cancer	3.84e-06	0.00011	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTO1—prostate cancer	3.84e-06	0.00011	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ESR1—prostate cancer	3.79e-06	0.000108	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PLCB2—prostate cancer	3.69e-06	0.000106	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP2C18—prostate cancer	3.69e-06	0.000106	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LRP2—prostate cancer	3.69e-06	0.000106	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TNFRSF21—prostate cancer	3.67e-06	0.000105	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—P4HB—prostate cancer	3.61e-06	0.000103	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP7B1—prostate cancer	3.57e-06	0.000102	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MTAP—prostate cancer	3.57e-06	0.000102	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC22A1—prostate cancer	3.52e-06	0.000101	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SULT1E1—prostate cancer	3.48e-06	9.95e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SRD5A1—prostate cancer	3.48e-06	9.95e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SULT2A1—prostate cancer	3.43e-06	9.81e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MED12—prostate cancer	3.37e-06	9.65e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GNG5—prostate cancer	3.34e-06	9.58e-05	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—CREBBP—prostate cancer	3.32e-06	9.51e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HSD17B3—prostate cancer	3.32e-06	9.5e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ACSL4—prostate cancer	3.32e-06	9.5e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NCOA3—prostate cancer	3.22e-06	9.22e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PHGDH—prostate cancer	3.18e-06	9.1e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—UMPS—prostate cancer	3.18e-06	9.1e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ARG2—prostate cancer	3.18e-06	9.1e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LDHB—prostate cancer	3.12e-06	8.93e-05	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SERPINE1—prostate cancer	3.11e-06	8.92e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HPGDS—prostate cancer	3.07e-06	8.8e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.06e-06	8.76e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP2C19—prostate cancer	3.05e-06	8.74e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTT1—prostate cancer	2.98e-06	8.54e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ACHE—prostate cancer	2.98e-06	8.54e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PDHA1—prostate cancer	2.96e-06	8.46e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—UCP3—prostate cancer	2.96e-06	8.46e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTA3—prostate cancer	2.96e-06	8.46e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TCN2—prostate cancer	2.96e-06	8.46e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP2A6—prostate cancer	2.95e-06	8.44e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AKR1C3—prostate cancer	2.87e-06	8.21e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PRKACB—prostate cancer	2.85e-06	8.16e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP17A1—prostate cancer	2.82e-06	8.08e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.82e-06	8.07e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.82e-06	8.07e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTA4—prostate cancer	2.7e-06	7.74e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.7e-06	7.74e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NCOA2—prostate cancer	2.69e-06	7.7e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTA2—prostate cancer	2.63e-06	7.54e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.6e-06	7.45e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCG5—prostate cancer	2.6e-06	7.45e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC5A5—prostate cancer	2.57e-06	7.34e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTA1—prostate cancer	2.54e-06	7.28e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTO1—prostate cancer	2.51e-06	7.2e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.51e-06	7.2e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NAT2—prostate cancer	2.51e-06	7.2e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP2E1—prostate cancer	2.51e-06	7.17e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NQO1—prostate cancer	2.48e-06	7.09e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TH—prostate cancer	2.44e-06	6.99e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.42e-06	6.92e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.41e-06	6.9e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LRP2—prostate cancer	2.41e-06	6.9e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PLCB2—prostate cancer	2.41e-06	6.9e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.38e-06	6.8e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—P4HB—prostate cancer	2.36e-06	6.77e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GGT1—prostate cancer	2.3e-06	6.59e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.3e-06	6.58e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NCOA1—prostate cancer	2.27e-06	6.49e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.24e-06	6.41e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.23e-06	6.39e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MED12—prostate cancer	2.2e-06	6.31e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GNG5—prostate cancer	2.19e-06	6.26e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—RXRA—prostate cancer	2.16e-06	6.17e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NCOA3—prostate cancer	2.11e-06	6.03e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—COMT—prostate cancer	2.08e-06	5.94e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTP1—prostate cancer	2.07e-06	5.92e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ITPR1—prostate cancer	2.03e-06	5.82e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HPGDS—prostate cancer	2.01e-06	5.75e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2C19—prostate cancer	2e-06	5.72e-05	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MYC—prostate cancer	1.97e-06	5.64e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTT1—prostate cancer	1.95e-06	5.58e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ACHE—prostate cancer	1.95e-06	5.58e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.93e-06	5.52e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TYMS—prostate cancer	1.92e-06	5.5e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTM1—prostate cancer	1.9e-06	5.44e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.87e-06	5.37e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PRKACB—prostate cancer	1.86e-06	5.34e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LPL—prostate cancer	1.86e-06	5.34e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.85e-06	5.28e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.8e-06	5.15e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ERCC2—prostate cancer	1.79e-06	5.11e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NCOA2—prostate cancer	1.76e-06	5.03e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MTHFR—prostate cancer	1.68e-06	4.8e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.68e-06	4.8e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPARA—prostate cancer	1.65e-06	4.71e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.64e-06	4.69e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NQO1—prostate cancer	1.62e-06	4.64e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TH—prostate cancer	1.6e-06	4.57e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.55e-06	4.45e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CAV1—prostate cancer	1.55e-06	4.43e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GGT1—prostate cancer	1.5e-06	4.31e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NCOA1—prostate cancer	1.48e-06	4.24e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.46e-06	4.18e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.41e-06	4.04e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—RXRA—prostate cancer	1.41e-06	4.03e-05	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—AKT1—prostate cancer	1.37e-06	3.91e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—COMT—prostate cancer	1.36e-06	3.89e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTP1—prostate cancer	1.35e-06	3.87e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—INS—prostate cancer	1.33e-06	3.82e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ITPR1—prostate cancer	1.33e-06	3.81e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CREBBP—prostate cancer	1.31e-06	3.74e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TYMS—prostate cancer	1.26e-06	3.6e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTM1—prostate cancer	1.24e-06	3.55e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.24e-06	3.55e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LPL—prostate cancer	1.22e-06	3.49e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.18e-06	3.37e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NOS3—prostate cancer	1.17e-06	3.35e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ERCC2—prostate cancer	1.17e-06	3.34e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MTHFR—prostate cancer	1.1e-06	3.14e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.08e-06	3.09e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPARA—prostate cancer	1.08e-06	3.08e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS2—prostate cancer	1.07e-06	3.06e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CAV1—prostate cancer	1.01e-06	2.9e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTEN—prostate cancer	9.34e-07	2.67e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CG—prostate cancer	9.22e-07	2.64e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—EP300—prostate cancer	8.9e-07	2.55e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—INS—prostate cancer	8.73e-07	2.5e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CREBBP—prostate cancer	8.55e-07	2.45e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CD—prostate cancer	8.1e-07	2.32e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NOS3—prostate cancer	7.65e-07	2.19e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.06e-07	2.02e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS2—prostate cancer	7e-07	2e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CA—prostate cancer	6.59e-07	1.89e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTEN—prostate cancer	6.1e-07	1.75e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—EP300—prostate cancer	5.82e-07	1.67e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AKT1—prostate cancer	5.38e-07	1.54e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.31e-07	1.23e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AKT1—prostate cancer	3.52e-07	1.01e-05	CbGpPWpGaD
